Simulations Plus (NASDAQ:SLP) Sets New 12-Month Low – Time to Sell?

Shares of Simulations Plus, Inc. (NASDAQ:SLP) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $26.51 and last traded at $26.51, with a volume of 24606 shares trading hands. The stock had previously closed at $30.39.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on SLP shares. BTIG Research dropped their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, October 24th. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday. Stephens assumed coverage on Simulations Plus in a report on Friday, November 15th. They issued an “overweight” rating and a $39.00 price target for the company. Finally, StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $51.40.

Simulations Plus Stock Down 17.3 %

The business’s 50 day moving average is $29.78 and its two-hundred day moving average is $34.16. The firm has a market capitalization of $504.54 million, a P/E ratio of 51.27 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The firm had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The firm’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.18 earnings per share. As a group, equities analysts anticipate that Simulations Plus, Inc. will post 1.1 earnings per share for the current fiscal year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total transaction of $635,200.00. Following the transaction, the director now directly owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 19.40% of the company’s stock.

Institutional Trading of Simulations Plus

Several institutional investors have recently made changes to their positions in the stock. Bank of New York Mellon Corp boosted its position in Simulations Plus by 5.2% during the second quarter. Bank of New York Mellon Corp now owns 222,317 shares of the technology company’s stock valued at $10,809,000 after purchasing an additional 11,048 shares during the last quarter. Arizona State Retirement System bought a new stake in shares of Simulations Plus in the 2nd quarter valued at approximately $218,000. Los Angeles Capital Management LLC acquired a new position in Simulations Plus in the second quarter worth approximately $206,000. Wedbush Securities Inc. raised its position in Simulations Plus by 10.5% during the second quarter. Wedbush Securities Inc. now owns 18,025 shares of the technology company’s stock valued at $876,000 after acquiring an additional 1,709 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its stake in Simulations Plus by 1.5% in the second quarter. Envestnet Asset Management Inc. now owns 54,813 shares of the technology company’s stock valued at $2,665,000 after acquiring an additional 784 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.